| Market Cap | 379M 334M 316M 286M 539M 36.29B 545M 3.79B 1.46B 18.56B 1.42B 1.39B 59.6B | P/E 2026 * |
36x | P/E 2027 * | 10.9x |
|---|---|---|---|---|---|
| Enterprise Value | 379M 334M 316M 286M 539M 36.29B 545M 3.79B 1.46B 18.56B 1.42B 1.39B 59.6B | EV / Sales 2026 * |
5.22x | EV / Sales 2027 * | 3.67x |
| Free-Float |
80.6% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Fennec Pharmaceuticals Inc.
| Manager | Title | Age | Since |
|---|---|---|---|
Jeffrey Hackman
CEO | Chief Executive Officer | 64 | 2024-08-15 |
Robert Andrade
DFI | Director of Finance/CFO | 51 | 2010-01-05 |
Pierre Sayad
CTO | Chief Tech/Sci/R&D Officer | 51 | 2024-10-27 |
| Director | Title | Age | Since |
|---|---|---|---|
Chris Rallis
BRD | Director/Board Member | 72 | 2011-08-24 |
Khalid Islam
CHM | Chairman | 69 | 2015-12-08 |
Marco Brughera
BRD | Director/Board Member | 70 | 2016-08-09 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 379M | |
| -2.33% | -1.12% | +59.27% | +115.42% | 1,056B | |
| -1.06% | -1.65% | +45.77% | +69.98% | 645B | |
| -0.65% | -1.36% | +17.22% | +75.49% | 465B | |
| -2.66% | -3.71% | +84.92% | +41.15% | 368B | |
| -0.06% | -4.12% | +36.31% | +39.39% | 335B | |
| -0.79% | +3.01% | +21.11% | +27.79% | 275B | |
| -1.19% | -3.09% | +10.75% | +10.61% | 255B | |
| -0.50% | +2.75% | +53.85% | +56.84% | 229B | |
| -1.47% | -2.37% | +32.35% | +98.89% | 188B | |
| Average | -0.22% | +0.12% | +40.17% | +59.51% | 423.98B | |
| Weighted average by Cap. | -0.03% | +0.30% | +44.68% | +71.39% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 72.56M 64.05M 60.61M 54.72M 103M 6.95B 104M 726M 279M 3.56B 272M 267M 11.42B | 103M 91.01M 86.12M 77.75M 147M 9.88B 148M 1.03B 397M 5.05B 387M 379M 16.23B |
| Net income | 10.48M 9.25M 8.75M 7.9M 14.91M 1B 15.09M 105M 40.34M 514M 39.34M 38.49M 1.65B | 35.13M 31.01M 29.34M 26.49M 49.99M 3.37B 50.58M 351M 135M 1.72B 132M 129M 5.53B |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
